TABLE 7.

G. lucidum (GL) reduces fasting glucose levels, glucose tolerance, and insulin tolerance in HFD-fed mice.

Groups	Fasting blood glucose (mg/dl)	Glucose tolerance (mg/dL)	Insulin tolerance (mg/dL)
ND	90	122	166
ND + GL	98	116	169
HFD	168	218	247
HFD + GL	118	171	168

Data source: (Jung et al., 2018) In HFD-fed, animals, GL, decreased fasting blood glucose, glucose tolerance, and insulin tolerance. Oral administration of GL (50 mg/kg) or vehicle five times per week to mice fed a normal diet (ND) or a high-fat diet (HFD). Once every 2 weeks, the mice were fasted for 16 h to assess their blood glucose levels. At 14 weeks of GL, therapy, mice (n = 8–9) were fasted for 16 h to conduct the GTT, and ITT (n = 8–9 for each group). Statistics are the mean.